sk&f-38393 has been researched along with zelandopam in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, S; Iwatsuki, K; Ren, LM | 1 |
| Chiba, S; Horiuchi, A; Iwatsuki, K; Ren, LM | 1 |
| Kano, H; Kohno, M; Minami, M; Yasunari, K; Yokokawa, K; Yoshikawa, J | 1 |
| Hasuma, T; Horio, T; Kano, H; Kohno, M; Minami, M; Yasunari, K; Yokokawa, K; Yoshikawa, J | 1 |
| Hanehira, T; Kano, H; Kohno, M; Minami, M; Yasunari, K; Yoshikawa, J | 1 |
1 review(s) available for sk&f-38393 and zelandopam
| Article | Year |
|---|---|
Anti-atherosclerotic action of vascular D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arteriosclerosis; Cell Division; Cell Movement; Dopamine; Dopamine Agonists; Hypertrophy; Isoquinolines; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Receptors, Dopamine D1; Tetrahydroisoquinolines | 1999 |
4 other study(ies) available for sk&f-38393 and zelandopam
| Article | Year |
|---|---|
Effects of YM435, a novel dopamine D1 receptor agonist, on pancreatic exocrine secretion in anesthetized dogs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dogs; Dopamine; Dose-Response Relationship, Drug; Female; Isoquinolines; Male; Pancreas; Pancreatic Juice; Receptors, Dopamine D1; Tetrahydroisoquinolines | 1992 |
D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia; Animals; Benzazepines; Dogs; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Isoquinolines; Pancreas; Pancreatic Juice; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Tetrahydroisoquinolines; Vasodilator Agents | 1995 |
Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Becaplermin; Benzazepines; Cells, Cultured; Colforsin; Dopamine Antagonists; Hypertrophy; Isoquinolines; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Rats; Receptors, Dopamine D1; Renal Artery; Sulfonamides; Tetrahydroisoquinolines | 1997 |
Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Animals; Becaplermin; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cell Movement; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enzyme Activation; Enzyme Inhibitors; Growth Inhibitors; Isoquinolines; Muscle, Smooth, Vascular; Naphthalenes; Phospholipase D; Platelet-Derived Growth Factor; Protein Kinase C; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Receptors, Dopamine D1; Renal Artery; Signal Transduction; Sulfonamides; Tetrahydroisoquinolines | 1997 |